JP2023520676A5 - - Google Patents
Info
- Publication number
- JP2023520676A5 JP2023520676A5 JP2022558017A JP2022558017A JP2023520676A5 JP 2023520676 A5 JP2023520676 A5 JP 2023520676A5 JP 2022558017 A JP2022558017 A JP 2022558017A JP 2022558017 A JP2022558017 A JP 2022558017A JP 2023520676 A5 JP2023520676 A5 JP 2023520676A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antagonist
- subject
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063001224P | 2020-03-27 | 2020-03-27 | |
| US63/001,224 | 2020-03-27 | ||
| EP21315010 | 2021-01-28 | ||
| EP21315010.5 | 2021-01-28 | ||
| PCT/US2021/024419 WO2021195530A1 (en) | 2020-03-27 | 2021-03-26 | Methods for treating atopic dermatitis by administering an il-4r antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520676A JP2023520676A (ja) | 2023-05-18 |
| JP2023520676A5 true JP2023520676A5 (https=) | 2024-04-03 |
Family
ID=75498103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558017A Pending JP2023520676A (ja) | 2020-03-27 | 2021-03-26 | Ｉｌ－４ｒアンタゴニストを投与することによりアトピー性皮膚炎を処置するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230102151A1 (https=) |
| EP (1) | EP4126951A1 (https=) |
| JP (1) | JP2023520676A (https=) |
| KR (1) | KR20220158821A (https=) |
| CN (1) | CN115427450A (https=) |
| AU (1) | AU2021244266A1 (https=) |
| BR (1) | BR112022015363A2 (https=) |
| CA (1) | CA3173173A1 (https=) |
| IL (1) | IL296214A (https=) |
| MX (1) | MX2022011730A (https=) |
| WO (1) | WO2021195530A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| TWI682781B (zh) | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| HUE067888T2 (hu) | 2016-09-01 | 2024-11-28 | Regeneron Pharma | Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| WO2021026205A1 (en) | 2019-08-05 | 2021-02-11 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
| IL310962A (en) | 2021-08-23 | 2024-04-01 | Regeneron Pharma | Methods for treating atopic dermatitis by administering an IL-4R antagonist |
| US20230220089A1 (en) * | 2021-12-30 | 2023-07-13 | Regeneron Pharmaceuticals, Inc. | Methods for attenuating atopic march by administering an il-4/il-13 antagonist |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2990420T3 (en) | 2000-05-26 | 2017-04-03 | Immunex Corp | USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| BRPI0416603A (pt) | 2003-11-07 | 2007-01-30 | Immunex Corp | anticorpo que se liga ao receptor interleucina-4 (il-4) humano |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| AU2017220184B2 (en) * | 2016-02-19 | 2024-04-18 | Regeneron Pharmaceuticals, Inc. | Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| WO2018057776A1 (en) | 2016-09-22 | 2018-03-29 | Regeneron Pharmaceuticals, Inc. | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
-
2021
- 2021-03-26 MX MX2022011730A patent/MX2022011730A/es unknown
- 2021-03-26 EP EP21718786.3A patent/EP4126951A1/en active Pending
- 2021-03-26 US US17/907,070 patent/US20230102151A1/en not_active Abandoned
- 2021-03-26 BR BR112022015363A patent/BR112022015363A2/pt unknown
- 2021-03-26 JP JP2022558017A patent/JP2023520676A/ja active Pending
- 2021-03-26 IL IL296214A patent/IL296214A/en unknown
- 2021-03-26 KR KR1020227037517A patent/KR20220158821A/ko active Pending
- 2021-03-26 CN CN202180024611.8A patent/CN115427450A/zh active Pending
- 2021-03-26 CA CA3173173A patent/CA3173173A1/en active Pending
- 2021-03-26 WO PCT/US2021/024419 patent/WO2021195530A1/en not_active Ceased
- 2021-03-26 AU AU2021244266A patent/AU2021244266A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520676A5 (https=) | ||
| JP2025172841A5 (https=) | ||
| JP2022543612A5 (https=) | ||
| US20240417455A1 (en) | Treatment for rheumatoid arthritis | |
| JP2021523188A5 (https=) | ||
| HRP20181227T1 (hr) | Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r | |
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| RU2019111921A (ru) | Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r | |
| JP2024174962A5 (https=) | ||
| JP2019529560A5 (https=) | ||
| JP2020500152A5 (https=) | ||
| JP2021502349A5 (https=) | ||
| JP2024532263A5 (https=) | ||
| EP4477265A2 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| JP2024530954A5 (https=) | ||
| JP2024016237A5 (https=) | ||
| CN104244978A (zh) | 通过施用丝氨酸蛋白酶抑制剂治疗或预防流感病毒感染的方法 | |
| JP2025501239A5 (https=) | ||
| JP2021147383A (ja) | アトピー性皮膚炎及び関連障害を処置するための方法 | |
| EP4126943B1 (en) | Methods for treating atopic dermatitis and related disorders | |
| RU2024129648A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2022105374A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2024107446A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2024121393A (ru) | Способы ослабления атопического марша посредством введения антагониста il-4/il-13 | |
| RU2020140639A (ru) | Способы лечения атопического дерматита посредством введения ингибитора ил-4r |